# Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin

> **NCT00022178** · PHASE3 · UNKNOWN · sponsor: **The Christie NHS Foundation Trust**

## Conditions studied

- Carcinoma of Unknown Primary

## Interventions

- **DRUG:** cisplatin
- **DRUG:** cyclophosphamide
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** epirubicin hydrochloride
- **DRUG:** fluorouracil
- **DRUG:** vincristine sulfate

## Key facts

- **NCT ID:** NCT00022178
- **Lead sponsor:** The Christie NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1998-12
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2013-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00022178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00022178, "Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00022178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*